Kathryn Mesa

Title: Innovations by Kathryn Mesa in HIV-1 Vaccine Development

Introduction

Kathryn Mesa is a prominent inventor based in Santa Cruz, CA, who has made significant contributions to the field of HIV-1 vaccine development. With a total of 3 patents, her work focuses on creating innovative immunogens that can elicit broadly neutralizing antibodies against HIV-1.

Latest Patents

Among her latest patents is the development of polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp120. This patent details the creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds that contain sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120. These immunogens are designed to bind multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans. Another notable patent involves V1/V2 fragments of the HIV-1 envelope glycoprotein, which includes naturally occurring and novel engineered epitopes that can be used to elicit and are recognized by broadly neutralizing antibodies.

Career Highlights

Kathryn Mesa is affiliated with the University of California, where she continues her research and development efforts in the field of immunology and vaccine design. Her innovative approaches have positioned her as a key figure in the ongoing fight against HIV.

Collaborations

Some of her notable coworkers include Phillip Berman and Bin Yu, who have collaborated with her on various research projects aimed at advancing HIV-1 vaccine technology.

Conclusion

Kathryn Mesa's contributions to HIV-1 vaccine development through her patents and research collaborations highlight her commitment to addressing one of the most pressing health challenges of our time. Her work continues to inspire advancements in immunology and vaccine research.